相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Csmd1 during Mammary Gland Development
Samuel J. Burgess et al.
GENES (2021)
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2enegative advanced breast cancer: final overall survival results from SOLAR-1
F. Andre et al.
ANNALS OF ONCOLOGY (2021)
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass
Mark Borris D. Aldonza et al.
SCIENTIFIC REPORTS (2021)
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Reversal of ABCB1-related multidrug resistance by ERK5-IN-1
Fang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Cell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kristina V. Kitaeva et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K. Gupta et al.
CANCERS (2020)
Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients
Yansong Liu et al.
BMC PSYCHIATRY (2019)
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
Richard D. A. Wilkinson et al.
JOURNAL OF ONCOLOGY (2019)
Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility
Arthur S. Lee et al.
NATURE COMMUNICATIONS (2019)
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
Johan Vallon-Christersson et al.
SCIENTIFIC REPORTS (2019)
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Kara M. Ruicci et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Collagen VI Contains Multiple Host Defense Peptides with Potent In Vivo Activity
Suado M. Abdillahi et al.
JOURNAL OF IMMUNOLOGY (2018)
Novel potential inhibitors of complement system and their roles in complement regulation and beyond
Chrysostomi Gialeli et al.
MOLECULAR IMMUNOLOGY (2018)
Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis
Jaya Gautam et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion
Mohamed Kamal et al.
ONCOLOGY REPORTS (2017)
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
Qiao Zhu et al.
BMC CANCER (2016)
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
Astrid Escudero-Esparza et al.
ONCOTARGET (2016)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
Minghui Zhang et al.
TARGETED ONCOLOGY (2014)
EGF receptor trafficking: consequences for signaling and cancer
Alejandra Tomas et al.
TRENDS IN CELL BIOLOGY (2014)
Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients
Rui Zhang et al.
TUMOR BIOLOGY (2014)
The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly
Astrid Escudero-Esparza et al.
FASEB JOURNAL (2013)
Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1
Vidar M. Steen et al.
PLOS ONE (2013)
CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway
Ming-Rui Tang et al.
APOPTOSIS (2012)
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
Pengyuan Liu et al.
CARCINOGENESIS (2012)
Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells
Ming-Fei Lang et al.
PLOS ONE (2012)
Effects of EpCAM overexpression on human breast cancer cell lines
Johanna M. Gostner et al.
BMC CANCER (2011)
Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF
Hanna Bjorkelund et al.
PLOS ONE (2011)
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma
Mohamed Kamal et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
Genetic, molecular and functional analyses of complement factor I deficiency
Sara C. Nilsson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Allelic Imbalances and Homozygous Deletion on 8p23.2 for Stepwise Progression of Hepatocarcinogenesis
Yutaka Midorikawa et al.
HEPATOLOGY (2009)
Functional selectivity of EGF family peptide growth factors: Implications for cancer
Kristy J. Wilson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Characterization of a novel tripartite nuclear localization sequence in the EGFR family
Sheng-Chieh Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues
Damian M. Kraus et al.
JOURNAL OF IMMUNOLOGY (2006)
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
Toni M. Richter et al.
CANCER CELL INTERNATIONAL (2005)
The gelsolin family of actin regulatory proteins: modular structures, versatile functions
AM McGough et al.
FEBS LETTERS (2003)
Identification of two new members of the CSMD gene family
WL Lau et al.
GENOMICS (2003)
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis
C Toomes et al.
GENES CHROMOSOMES & CANCER (2003)
The role of CSMDI in head and neck carcinogenesis
SB Scholnick et al.
GENES CHROMOSOMES & CANCER (2003)
The biology of neoadjuvant chemotherapy for breast cancer
S Cleator et al.
ENDOCRINE-RELATED CANCER (2002)
Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies
KE Longva et al.
JOURNAL OF CELL BIOLOGY (2002)
Transcript map of the 8p23 putative tumor suppressor region
PC Sun et al.
GENOMICS (2001)
分享论文
